Both immune-sorting and aldefluor assays revealed that human breast tumors harboured a higher population of both CD44+/CD24− (Fig. 1A) and ALDH+ (aldehyde dehydrogenasehigh) cells (p < 0.001), compared to normal tissues (Fig. 1B). This evidence concerns the gene CD44 and breast neoplasm.